Quality of Life of Periodontitis Patients Visiting Supportive Periodontal Therapy

April 14, 2022 updated by: Kristina Bertl, Medical University of Vienna

Evaluation of the Quality of Life of Periodontitis Patients Visiting Supportive Periodontal Therapy - A Prospective Study

The present prospective study aims to assess the QoL of periodontitis patients during supportive treatment and to relate it to periodontal health (clinical and radiographic data) and treatment stability. Follow-ups after the first cross-sectional assessment are planned after approximately 2.5, 5, 7.5, and 10 years.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Anticipated)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Austria
      • Vienna, Austria, 1090
        • Recruiting
        • Division of Oral Surgery, School of Dentistry, Medical University of Vienna
        • Contact:
          • Kristina Bertl

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 126 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

periodontitis patients undergoing supportive treatment

Description

Inclusion Criteria:

  • All patients returning for supportive therapy on a regular basis after active periodontal treatment will be asked for participation if they are in supportive therapy for at least 1 year.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
disease specific OHRQoL (ParoQoL)
Time Frame: at baseline
at baseline
disease specific OHRQoL (ParoQoL)
Time Frame: after 2.5 years
after 2.5 years
disease specific OHRQoL (ParoQoL)
Time Frame: after 5 years
after 5 years
disease specific OHRQoL (ParoQoL)
Time Frame: after 7.5 years
after 7.5 years
disease specific OHRQoL (ParoQoL)
Time Frame: after 10 years
after 10 years

Secondary Outcome Measures

Outcome Measure
Time Frame
Oral Health Impact Profile (OHIP)
Time Frame: at baseline
at baseline
perceived stress scale (PSS)
Time Frame: at baseline
at baseline
overall health status of the patients (EQ5D-5L)
Time Frame: at baseline
at baseline
Oral Health Impact Profile (OHIP)
Time Frame: after 2.5 years
after 2.5 years
perceived stress scale (PSS)
Time Frame: after 2.5 years
after 2.5 years
overall health status of the patients (EQ5D-5L)
Time Frame: after 2.5 years
after 2.5 years
Oral Health Impact Profile (OHIP)
Time Frame: after 5 years
after 5 years
perceived stress scale (PSS)
Time Frame: after 5 years
after 5 years
overall health status of the patients (EQ5D-5L)
Time Frame: after 5 years
after 5 years
Oral Health Impact Profile (OHIP)
Time Frame: after 7.5 years
after 7.5 years
perceived stress scale (PSS)
Time Frame: after 7.5 years
after 7.5 years
overall health status of the patients (EQ5D-5L)
Time Frame: after 7.5 years
after 7.5 years
Oral Health Impact Profile (OHIP)
Time Frame: after 10 years
after 10 years
perceived stress scale (PSS)
Time Frame: after 10 years
after 10 years
overall health status of the patients (EQ5D-5L)
Time Frame: after 10 years
after 10 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Medical University of Vienna

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 10, 2022

Primary Completion (Anticipated)

December 1, 2032

Study Completion (Anticipated)

December 1, 2033

Study Registration Dates

First Submitted

April 8, 2022

First Submitted That Met QC Criteria

April 14, 2022

First Posted (Actual)

April 21, 2022

Study Record Updates

Last Update Posted (Actual)

April 21, 2022

Last Update Submitted That Met QC Criteria

April 14, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1398/2021

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe